Search Results - "Bij de Vaate, EA"

Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment by Buis, DTP, van Werkhoven, CH, van Agtmael, MA, Bax, HI, Berrevoets, M, de Boer, MGJ, Bonten, MJM, Bosmans, JE, Branger, J, Douiyeb, S, Gelinck, LBS, Jong, E, Lammers, AJJ, Van der Meer, JTM, Oosterheert, JJ, Sieswerda, E, Soetekouw, R, Stalenhoef, JE, Van der Vaart, TW, Bij de Vaate, EA, Verkaik, NJ, Van Vonderen, MGA, De Vries, PJ, Prins, JM, Sigaloff, KCE, Botman, E, Van den Broek, A, Buitenhuis, L, Buitenwerf, E, Cents, A S, Engels, N, Hanssen, J L J, Meinders, A J, Mollema, F P N, Nagelmaker, L, van Doorn-Schepens, M L M, Roescher, N, Thomopoulos, P, Timmer, M, van der Wiel, B

“…IntroductionA major knowledge gap in the treatment of complicated Staphylococcus aureus bacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe…”
Get full text

Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study by Niessen, F.A., Bruijning-Verhagen, P.C.J.L., Bonten, M.J.M., Peters, V., Ammerlaan, H.S.M., Delsing, C.E., Dijkstra, N.G., Bresser, P., Kramer, H., Rusch, D., bij de Vaate, E.A., Veen, P., Dofferhoff, A., Bruns, M., Terpstra, L.C., Thijs, W., Hassing, R., Huijbens, D.H., Jong, E., Knol, M.J.

“…Vaccination remains crucial in reducing COVID-19 hospitalizations and mitigating the strain on healthcare systems. We conducted a multicenter study to assess…”
Get full text